Evaluate the Efficacy and Safety of Brightening Micro-needle Patch on Facial Solar Lentigines

Solar Lentigines Clinical Trial

Official title: A Single Center, Randomized, Double-blind and Placebo Controlled Clinical Study to Evaluate the Efficacy and Safety of Brightening Micro-needle Patch on Facial Solar Lentigines

Status Completed

Clinical Trial Summary

This is a single center, randomized, double-blind and placebo controlled clinical study to evaluate the efficacy and safety of brightening microneedle patch on facial solar lentigines. Subjects who are 30 to 65-year-old with solar lentigines on their faces will receive brightening microneedle patches on facial solar lentigines once a day for 4 weeks. Afterwards, facial images and skin detectors will be used to analysis their skin, according to various skin tone indexes and skin response score sheets.

Clinical Trial Description

Method: 35 subjects, Fitzpatrick Skin Type II to IV. Each subject has at least two brown solar lentigines on the face, and the two spots are independent, each with a clear boundary and diameter ≥ 0.5 cm. This trial includes 1 screening visit (Day -1), wash-out period (2 weeks before the trial), trial period (4 weeks in total), and 3 return visits for detecting (baseline detecting at the end of the wash-out period, the 2nd week and the 4th week of the trial period). ;

Related Conditions & MeSH terms

• Lentigo
• Solar Lentigines

• NCT number: NCT04583852
• Study type: Interventional
• Source: Panion & BF Biotech Inc.
• Status: Completed
• Phase: N/A
• Start date: September 14, 2020
• Completion date: January 25, 2021